Aarti Drugs informs about investment in equity shares of WOS

07 Mar 2026 Evaluate

Aarti Drugs has informed that the Finance & Investment Committee at its Meeting held on Saturday, March 7, 2026, approved the investment in equity shares of Pinnacle Life Science, wholly owned subsidiary (WOS) of the Company, upto an aggregate value of INR 10,00,00,000, by way of subscription to the Rights Issue. The details as required under SEBI Listing Regulations read with SEBI Mater Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs Share Price

356.85 -3.65 (-1.01%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×